Vaccitech plc
VACC · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $15 | $45 | $0 | $5 |
| % Growth | -66.5% | 16,580.2% | -94.4% | – |
| Cost of Goods Sold | $0 | $42 | $20 | $14 |
| Gross Profit | $0 | $2 | -$20 | -$10 |
| % Margin | 0% | 5.3% | -7,501.1% | -198.5% |
| R&D Expenses | $42 | $41 | $16 | $11 |
| G&A Expenses | $30 | $6 | $25 | $10 |
| SG&A Expenses | $30 | $6 | $25 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $12 | $1 | $0 | $0 |
| Operating Expenses | $84 | $48 | $41 | $22 |
| Operating Income | $1 | -$3 | -$45 | -$20 |
| % Margin | 7.9% | -7.7% | -16,873.5% | -415.9% |
| Other Income/Exp. Net | -$62 | $5 | -$6 | $2 |
| Pre-Tax Income | -$61 | $1 | -$51 | -$18 |
| Tax Expense | -$0 | -$4 | -$0 | $0 |
| Net Income | -$61 | $5 | -$51 | -$18 |
| % Margin | -408% | 11.9% | -19,071.6% | -372% |
| EPS | -1.55 | 0.14 | -1.97 | -2.27 |
| % Growth | -1,207.1% | 107.1% | 13.2% | – |
| EPS Diluted | -1.55 | 0.14 | -1.97 | -2.27 |
| Weighted Avg Shares Out | 39 | 37 | 26 | 8 |
| Weighted Avg Shares Out Dil | 39 | 38 | 26 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $0 | $0 |
| Interest Expense | -$0 | $0 | $3 | $4 |
| Depreciation & Amortization | $0 | $4 | $4 | $4 |
| EBITDA | $1 | $5 | -$45 | -$17 |
| % Margin | 7.9% | 11.6% | -16,873.5% | -342.7% |